Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease
Clinical trial NCT00004642 · COMPLETED
Trial details
- NCT number
- NCT00004642
- Sponsor
- National Center for Research Resources (NCRR)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1995-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.